Danaher | DHR - Current Assets

Stock Price
177.25
Daily Change
-1.32 -0.74%
Monthly
-5.29%
Yearly
-10.09%
Q2 Forecast
173.46

Danaher reported $13.94B in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Abbott USD 26B 1.16B Dec/2025
Agilent USD 4.62B 21M Dec/2025
Align Technology USD 2.62B 82.47M Dec/2025
Becton, Dickinson and Co. USD 9.19B 66M Dec/2025
Bio Techne USD 637.43M 27.92M Dec/2025
Bio-Rad Laboratories USD 2.91B 64.2M Dec/2025
Boston Scientific USD 8.79B 759M Dec/2025
Bruker USD 2.21B 138.1M Dec/2025
Charles River Laboratories USD 1.45B 85.06M Dec/2025
Danaher USD 13.94B 1.18B Mar/2026
Dentsply International USD 2.02B 49M Dec/2025
Edwards Lifesciences USD 6.74B 380M Dec/2025
ESCO Technologies USD 689.65M 1.15M Dec/2025
Fortive USD 1.61B 125.9M Dec/2025
Henry Schein USD 4.46B 69M Dec/2025
Illumina USD 3.29B 493M Dec/2025
Intuitive Surgical USD 11.52B 881.5M Mar/2026
IQVIA Holdings USD 6.25B 270M Dec/2025
Keysight Technologies USD 4.7B 353M Dec/2025
Laboratory Of America USD 4.02B 58.3M Dec/2025
Medtronic USD 24.07B 75M Dec/2025
Mettler Toledo International USD 1.36B 81.46M Dec/2025
Myriad Genetics USD 332.6M 12.2M Dec/2025
OraSure Technologies USD 261.91M 21.1M Dec/2025
Quest Diagnostics USD 2.57B 188M Mar/2026
Quidel USD 1.45B 80.6M Dec/2025
Repligen USD 1.14B 40.9M Dec/2025
Revvity USD 2.24B 95.96M Dec/2025
Roper Industries USD 1.91B 16M Mar/2026
Stryker USD 14.76B 1.04B Dec/2025
Thermo Fisher Scientific USD 22.32B 6.39B Mar/2026
Waters USD 1.99B 69.86M Dec/2025
Zimmer Biomet Holdings USD 5.12B 715M Dec/2025